Primary tabs

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents - A Phase II Study

To evaluate the efficacy of a combined treatment with Cilengitide and metronomic oral Temozolomide in children and adolescents with relapsed or refractory high-grade malignant glioma and diffuse intrinsic pontine glioma as indicated by 6 months overall survival OS after diagnosis of relapse or tumour progression in comparison to a historical control group of paediatric HGG relapse patients from the HIT-GBMHIT-HGG data base

FieldValue
Modified
2019-04-21
Release Date
2018-03-05
Identifier
0391ecec-1a63-438a-a790-a7a9fbbc2c7e
License
Public Access Level
Public